ACE2 and melanoma: However, the immunohistochemical evaluation of ACE2 presence in healthy and oncologic patients showed ACE2 in the basal cell layer of the normal epidermis and reduced ACE2 reactivity in patients affected by pre-malignant lesions and non-melanoma malignant skin cancers [412].